Stocks in play: Doseology Sciences Inc

Announces the appointment of Shawn Balaghi as a director of the Company, and Lindsay Hamelin as Corporate Secretary of the Company. Shawn brings over 20 years of experience in the capital markets industry globally, holding key roles in finance, corporate development, and strategic planning. Previously, he has served as the CEO and CFO for several publicly listed companies and has worked closely with some of the largest independent auditing firms in Canada and the US. Shawn has raised over $300 Million in funding for several start-ups and has led them to public listings in Canada, the US, and Germany. Lindsay has 17 years experience as a self-employed consultant and working in leading Canadian law firms. She has focused on securities and corporate finance and assists with managing and orchestrating public company requirements with a focus on the CSE, TSXV and TSX stock exchanges, as well as listings on the OTC Markets. Doseology Sciences Inc shares C.MOOD are trading unchanged at $0.03.